Pioneering solutions to save and improve lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
Sponsors wishing to support clinical trials should contact the Foundation on +61 3 9342 8447 or email neuro.foundation@mh.org.au.
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy
A Phase 2, Randomised, Controlled Trial of Sodium Selenate as a Disease-modifying Treatment for Chronic Drug-resistant Temporal Lobe Epilepsy
Dyskinesia and pain may share common pathophysiological mechanisms in Parkinson's disease: A fMRI study
A single arm, open-label, phase I study to evaluate the safety and tolerability of ISC-hpNSC injected into the striatum and substantia nigra of patients with Parkinson's disease